Breast Cancer In Focus: Next-Generation Targeted Agents in HER2-Positive Metastatic Breast Cancer

Edith A. Perez, MD Deputy Director at Large, Mayo Clinic Cancer Center Group Vice Chair, Alliance for Clinical Trials in Oncology Serene M. and Frances C. […]

Clinical Trials in Squamous Cell Carcinoma of the Head and Neck

Marshall Posner, MD Director, Head and Neck Medical Oncology Director, Office of Cancer Clinical Trials Professor of Gene and Cell Medicine The Tisch Cancer Institute Mount […]

Regorafenib in Metastatic Colorectal Cancer

Axel Grothey, MD Professor of Oncology Mayo Clinic Rochester, Minnesota H&O What are the traditional palliative treatments in metastatic colorectal cancer? AG Only a small subset […]

Safety of Chemotherapy in Pregnancy

Frédéric Amant, MD, PhD Head of Gynaecological Oncology Professor Leuven Cancer Institute Katholieke Universiteit Leuven, Belgium H&O Traditionally, what has been the approach to administration of […]

Breast Cancer In Focus: Emerging Nontaxane Therapies for Metastatic Breast Cancer

Ruth O’Regan, MD Director of Translational Breast Cancer Research Professor Hematology and Oncology, Medical Oncology The Winship Cancer Institute Emory University Atlanta, Georgia H&O What is […]

The Need for Postoperative Radiation Therapy

Beryl McCormick, MD, FACR Chief, External Beam Radiotherapy Service Memorial Sloan-Kettering Cancer Center New York, New York H&O What is the current standard of care for […]

Breast Cancer In Focus: Treatment Options for Triple-Negative Metastatic Breast Cancer

Joyce A. O’Shaughnessy, MD Celebrating Women Chair in Breast Cancer Research Texas Oncology-Baylor Charles A. Sammons Cancer Center US Oncology Dallas, Texas H&O Can you discuss the […]

Molecular Marker Analyses From the SATURN Trial

Wolfram Brugger, MD, PhD Schwarzwald-Baar Klinikum, Academic Teaching Hospital University of Freiburg Villingen-Schwenningen, Germany H&O Can you discuss the SATURN trial? WB he SATURN (Sequential Tarceva in […]

Colorectal Cancer In Focus: Liver-Directed Therapies in Colorectal Cancer

Michael Choti, MD, MBA The Jacob C. Handelsman Professor of Surgery Chief of the Handelsman Division of Surgical Oncology Johns Hopkins University Baltimore, Maryland H&O Can you […]

Breast Cancer In Focus: Diet and Exercise in Breast Cancer

Jennifer A. Ligibel, MD Assistant Professor of Medicine Harvard Medical School Boston, Massachusetts H&O Why are diet and exercise important for breast cancer patients? JL Eating a healthy […]

KRAS: Guiding Treatment of Patients With Metastatic Colorectal Cancer

Wells Messersmith, MD, FACP Associate Professor Director, GI Medical Oncology Program co-Leader, Developmental Therapeutics University of Colorado Anschutz Medical Campus Denver, Colorado H&O How is KRAS mutational […]

Breast Cancer In Focus: Novel Targets for Triple-Negative Breast Cancer

Lisa A. Carey, MD Preyer Distinguished Professor of Breast Cancer Research Medical Director, UNC Breast Center UNC-Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina H&O Can you provide […]

Colorectal Cancer In Focus: Adjuvant Chemotherapy for Stage II and III Colorectal Cancer

Al B. Benson, III, MD Professor in Medicine-Hematology/Oncology Northwestern University Feinberg School of Medicine Chicago, Illinois H&O What are the factors that are considered when deciding who […]

Breast Cancer In Focus: Tumor Self-Seeding in Breast Cancer

Larry Norton, MD Deputy Physician-in-Chief, Breast Cancer Programs Medical Director, Evelyn H. Lauder Breast Center Norna S. Sarofim Chair in Clinical Oncology Memorial Sloan-Kettering Cancer Center […]

Breast Cancer in Focus: The Role of Albumin-Bound Paclitaxel in Metastatic Breast Cancer

Christy Russell, MD Associate Professor of Clinical Medicine Director of the USC/Norris Breast Center University of Southern California Los Angeles, California H&O What is albumin-bound paclitaxel and […]

Colorectal Cancer In Focus: Biomarkers to Predict Response to Anti-EGFR Antibodies

Sabine Tejpar, MD, PhD Associate Professor Department of Gastro Enterology Digestive Oncology Unit University Hospital Gasthuisberg Leuven, Belgium H&O What is the current status of molecular markers […]

Breast Cancer In Focus: Estrogen and Progesterone Receptors in Breast Cancer

Cynthia X. Ma, MD, PhD Assistant Professor Department of Medicine Washington University School of Medicine St. Louis, Missouri H&O Can you provide some background on estrogen receptor […]

Colorectal Cancer In Focus: The Role of Aspirin in Prevention and Management of Colorectal Cancer

Charles S. Fuchs, MD, MPH Director, Gastrointestinal Cancer Center Professor of Medicine Harvard Medical School Boston, Massachusetts H&O What are the possible benefits of daily aspirin use? […]

Nontaxane Microtubule Dynamics Inhibitors

Javier Cortes, MD Head of the Breast Cancer Program Vall D’Hebron Institute of Oncology Barcelona, Spain H&O What is the mechanism of action of nontaxane microtubule inhibitors? […]

Colorectal Cancer In Focus: Highlights of the 2011 Annual Meeting of the American Society of Clinical Oncology Gastrointestinal Cancers Symposium

Highlights of the 2011 Annual Meeting of the American Society of Clinical Oncology Gastrointestinal Cancers Symposium January 20–22, 2011 • San Francisco, California Complete abstracts are available […]